{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:42:09Z","timestamp":1791895329146,"version":"4.3.4"},"reference-count":314,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","award":["ZIA-DA000633"],"award-info":[{"award-number":["ZIA-DA000633"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","award":["1R15DA057501\\u201301A1"],"award-info":[{"award-number":["1R15DA057501\\u201301A1"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50AA017823"],"award-info":[{"award-number":["P50AA017823"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA-DA000633"],"award-info":[{"award-number":["ZIA-DA000633"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118327","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:49:53Z","timestamp":1751590193000},"page":"118327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Galaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118327_bib1","article-title":"The unmet treatment need for eating disorders: what has changed in more than 10\u2009years? an updated systematic review and meta-analysis","author":"Ali","year":"2024","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s40337-024-01130-9","article-title":"Early-onset anorexia nervosa: a scoping review and management guidelines","volume":"12","author":"Ayrolles","year":"2024","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib4","article-title":"Psychological characteristics of fathers of people with bulimia nervosa: a systematic review","author":"Akkese","year":"2024","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/14656566.2024.2428371","article-title":"Can we effectively manage binge eating disorder with pharmacotherapy?","volume":"25","author":"Hay","year":"2024","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","article-title":"The prevalence and correlates of eating disorders in the national comorbidity survey replication","volume":"61","author":"Hudson","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archgenpsychiatry.2011.22","article-title":"Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement","volume":"68","author":"Swanson","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5498\/wjp.v11.i9.517","article-title":"Binge eating and psychostimulant addiction","volume":"11","author":"Blanco-Gandia","year":"2021","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4","article-title":"Depression and eating disorders","volume":"8 1","author":"Casper","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopha.2025.118327_bib10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1176\/appi.ajp.161.12.2215","article-title":"Comorbidity of anxiety disorders with anorexia and bulimia nervosa","volume":"161","author":"Kaye","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.v65n0718","article-title":"Alcohol use disorder comorbidity in eating disorders: a multicenter study","volume":"65","author":"Bulik","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psychres.2019.01.007","article-title":"Prevalence of substance use disorder comorbidity among individuals with eating disorders: a systematic review and meta-analysis","volume":"273","author":"Bahji","year":"2019","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopha.2025.118327_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40337-022-00654-2","article-title":"Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature","volume":"10","author":"Hambleton","year":"2022","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2024.102486","article-title":"Unification of the food and alcohol disturbance literature: a systematic review","volume":"113","author":"Berry","year":"2024","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib15","first-page":"547","article-title":"Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders","volume":"41","author":"Killeen","year":"2015","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.biopha.2025.118327_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9814358","article-title":"Lifetime traumatic experiences and disordered eating among university students: the role of posttraumatic stress symptoms","volume":"2018","author":"Malinauskiene","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2025.118327_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neubiorev.2017.08.011","article-title":"Anorexia nervosa and bulimia nervosa: a meta-analysis of executive functioning","volume":"83","author":"Hirst","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib18","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text rev., 2000."},{"key":"10.1016\/j.biopha.2025.118327_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/eat.20599","article-title":"DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder","volume":"42","author":"Grilo","year":"2009","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40519-016-0313-5","article-title":"Medical comorbidity of binge eating disorder","volume":"22","author":"Olguin","year":"2017","journal-title":"Eat. Weight Disord. EWD"},{"key":"10.1016\/j.biopha.2025.118327_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4603(97)00046-4","article-title":"The role of weight control as a motivation for cocaine abuse","volume":"23","author":"Cochrane","year":"1998","journal-title":"Addict. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0272-7358(99)00009-4","article-title":"The relationship between eating disorders and substance use: moving beyond co-prevalence research","volume":"20","author":"Wolfe","year":"2000","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib23","first-page":"1","article-title":"WFSBP task force on eating disorders, world federation of societies of biological psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders","author":"Himmerich","year":"2023","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnut.2019.00069","article-title":"Activity based anorexia as an animal model for anorexia nervosa-a systematic review","volume":"6","author":"Schalla","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2025.118327_bib25","article-title":"Animal models for anorexia nervosa-a systematic review","volume":"14","author":"Scharner","year":"2020","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnins.2019.00059","article-title":"The anx\/anx mouse - a valuable resource in anorexia nervosa research","volume":"13","author":"Nilsson","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.molmed.2023.11.011","article-title":"Taking better advantage of the activity-based anorexia model","volume":"30","author":"Foldi","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.88","article-title":"Role of the ventral striatum in developing anorexia nervosa","volume":"3","author":"Fladung","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1017\/S0033291717001994","article-title":"Cue reactivity towards bodies in anorexia nervosa - common and differential effects in adolescents and adults","volume":"48","author":"Horndasch","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.appet.2016.08.001","article-title":"Explicit and implicit approach vs. avoidance tendencies towards high vs. low calorie food cues in patients with anorexia nervosa and healthy controls","volume":"107","author":"Paslakis","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.biopha.2025.118327_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neubiorev.2015.02.012","article-title":"A reward-centred model of anorexia nervosa: a focussed narrative review of the neurological and psychophysiological literature","volume":"52","author":"O\u2019Hara","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fnbeh.2014.00410","article-title":"Are extremes of consumption in eating disorders related to an altered balance between reward and inhibition?","volume":"8","author":"Wierenga","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1176\/appi.ajp.2009.09010071","article-title":"A neural signature of anorexia nervosa in the ventral striatal reward system","volume":"167","author":"Fladung","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pscychresns.2015.06.013","article-title":"Striatal dopamine type 2 receptor availability in anorexia nervosa","volume":"233","author":"Broft","year":"2015","journal-title":"Psychiatry Re.s"},{"key":"10.1016\/j.biopha.2025.118327_bib35","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1038\/s41380-019-0633-8","article-title":"Dopamine D2 receptor overexpression in the nucleus accumbens core induces robust weight loss during scheduled fasting selectively in female mice","volume":"26","author":"Welch","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.biopsych.2020.06.022","article-title":"Suppression of corticostriatal circuit activity improves cognitive flexibility and prevents body weight loss in activity-based anorexia in rats","volume":"90","author":"Milton","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib37","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.neubiorev.2010.12.012","article-title":"Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies","volume":"35","author":"Liu","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cpr.2015.04.005","article-title":"Emotion generation and regulation in anorexia nervosa: a systematic review and meta-analysis of self-report data","volume":"39","author":"Oldershaw","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib39","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s12276-020-00532-4","article-title":"Stress and the dopaminergic reward system","volume":"52","author":"Baik","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnsys.2015.00090","article-title":"Lateral hypothalamus, nucleus accumbens, and ventral pallidum roles in eating and hunger: interactions between homeostatic and reward circuitry","volume":"9","author":"Castro","year":"2015","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41386-022-01440-z","article-title":"Trait anxiety is associated with amygdala expectation and caloric taste receipt response across eating disorders","volume":"48","author":"Frank","year":"2023","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113355","article-title":"Central amygdala circuits in valence and salience processing","volume":"410","author":"Kong","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118327_bib43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.biopha.2025.118327_bib44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00787-016-0844-3","article-title":"A naturalistic examination of negative affect and disorder-related rumination in anorexia nervosa","volume":"25","author":"Seidel","year":"2016","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154462","article-title":"Negative mood increases selective attention to negatively valenced body parts in female adolescents with anorexia nervosa","volume":"11","author":"Svaldi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.118327_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.tem.2019.08.004","article-title":"A metabolic perspective on reward abnormalities in anorexia nervosa","volume":"30","author":"Duriez","year":"2019","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"10.1016\/j.biopha.2025.118327_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nrendo.2016.175","article-title":"The endocrine manifestations of anorexia nervosa: mechanisms and management","volume":"13","author":"Schorr","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib48","article-title":"Metabolic and neuroendocrine adaptations to undernutrition in anorexia nervosa: from a clinical to a basic research point of view","volume":"36","author":"Viltart","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.biopha.2025.118327_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cmet.2017.05.013","article-title":"Leptin\u2019s physiologic role: does the emperor of energy balance have no clothes?","volume":"26","author":"Flier","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbi.2021.04.013","article-title":"Anxiety-like behavior in female mice is modulated by STAT3 signaling in midbrain dopamine neurons","volume":"95","author":"Fernandes","year":"2021","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.biopha.2025.118327_bib51","article-title":"The utility of animal models for studying the metabo-psychiatric origins of anorexia nervosa","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14728222.2023.2206954","article-title":"Emerging therapeutic targets for anorexia nervosa","volume":"27","author":"Stengel","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2025.118327_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40337-021-00516-3","article-title":"The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis","volume":"9","author":"Devoe","year":"2021","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib54","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X16666180108111532","article-title":"Neurostimulation in clinical and sub-clinical eating disorders: a systematic update of the literature","volume":"16","author":"Dalton","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/YCO.0000000000000361","article-title":"Neuromodulation and neurofeedback treatments in eating disorders and obesity","volume":"30","author":"Dalton","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.addbeh.2017.08.004","article-title":"Neurostimulation techniques in the treatment of cocaine dependence: a review of the literature","volume":"76","author":"Rachid","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2015.03.016","article-title":"Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity","volume":"8","author":"Val-Laillet","year":"2015","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.biopha.2025.118327_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14656566.2020.1748600","article-title":"Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?","volume":"21","author":"Frank","year":"2020","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib59","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1080\/14656566.2024.2424316","article-title":"Pharmacotherapeutic strategies for the treatment of anorexia nervosa - novel targets to break a vicious cycle","volume":"25","author":"Kirchberg","year":"2024","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib60","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/sj.npp.1300264","article-title":"Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction","volume":"28","author":"Hutchison","year":"2003","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib61","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00213-014-3757-1","article-title":"Dose specific effects of olanzapine in the treatment of alcohol dependence","volume":"232","author":"Littlewood","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnut.2014.00019","article-title":"Could dopamine agonists aid in drug development for anorexia nervosa?","volume":"1","author":"Frank","year":"2014","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2025.118327_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial","volume":"176","author":"Attia","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib64","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1017\/S0033291711000390","article-title":"Olanzapine versus placebo for out-patients with anorexia nervosa","volume":"41","author":"Attia","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib65","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12888-014-0376-7","article-title":"Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background","volume":"14","author":"Brambilla","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2498","article-title":"Effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta-analysis","volume":"12","author":"Han","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib68","first-page":"197","article-title":"Evaluation of the effectiveness and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescents: an open-label trial","volume":"27","author":"Spettigue","year":"2018","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry J. Acad. Can. Psychiatr. Enfant Adolesc."},{"key":"10.1016\/j.biopha.2025.118327_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12888-024-06215-y","article-title":"Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study","volume":"24","author":"Said","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/a-2436-9552","article-title":"Impact of antipsychotic medications on weight gain and eating disorder-related psychopathology in adult inpatients with anorexia nervosa","volume":"58","author":"Bauman","year":"2025","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107845","article-title":"Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: a systematic review","volume":"208","author":"Fluyau","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2025.118327_bib73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.biopha.2025.118327_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.3869","article-title":"A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression","volume":"9","author":"Schwartz","year":"2021","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.biopha.2025.118327_bib76","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","article-title":"Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report","volume":"11","author":"Scolnick","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib77","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","article-title":"Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions","volume":"91","author":"Mills","year":"1998","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"10.1016\/j.biopha.2025.118327_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1181447","article-title":"Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa","volume":"14","author":"Keeler","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00429-023-02740-w","article-title":"Ketamine ameliorates activity-based anorexia of adolescent female mice through changes in GluN2B-containing NMDA receptors at postsynaptic cytoplasmic locations of pyramidal neurons and interneurons of medial prefrontal cortex","volume":"229","author":"Li","year":"2024","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.biopha.2025.118327_bib80","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.NAJ.0000546378.81550.84","article-title":"CE: acute pain management for people with opioid use disorder","volume":"118","author":"Broglio","year":"2018","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.biopha.2025.118327_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/npr2.12028","article-title":"Anticraving therapy for alcohol use disorder: a clinical review","volume":"38","author":"Shen","year":"2018","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.118327_bib82","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41398-021-01559-5","article-title":"Cerebral \u03bc-opioid and CB1 receptor systems have distinct roles in human feeding behavior","volume":"11","author":"Kantonen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004850-199510030-00005","article-title":"Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa","volume":"10","author":"Marrazzi","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/cap.2019.0056","article-title":"Naltrexone reduces binge eating and purging in adolescents in an eating disorder program","volume":"29","author":"Stancil","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","article-title":"Observational analysis of feeding induced by Delta9-THC and anandamide","volume":"76","author":"Williams","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.biopha.2025.118327_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00004714-198306000-00004","article-title":"A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa","volume":"3","author":"Gross","year":"1983","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib89","first-page":"44","article-title":"The impact of \u03949-THC on the psychological symptoms of anorexia nervosa: a pilot study","volume":"54","author":"Avraham","year":"2017","journal-title":"Isr. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146761","article-title":"The role of oxytocin in alcohol and drug abuse","volume":"1736","author":"King","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2025.118327_bib91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0313-z","article-title":"Targeting the oxytocin system to treat addictive disorders: rationale and progress to date","volume":"30","author":"Lee","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2025.118327_bib92","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/npp.2017.257","article-title":"Oxytocin reduces alcohol cue-reactivity in alcohol-dependent rats and humans","volume":"43","author":"Hansson","year":"2018","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib93","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.euroneuro.2014.06.005","article-title":"Complexity of oxytocin\u05f3s effects in a chronic cocaine dependent population","volume":"24","author":"Lee","year":"2014","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib94","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3062-4","article-title":"Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study","volume":"228","author":"McRae-Clark","year":"2013","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.biopha.2025.118327_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000496194","article-title":"The effects of oxytocin on withdrawal, craving and stress response in heroin-dependent patients: a randomized, double-blind clinical trial","volume":"25","author":"Moeini","year":"2019","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psyneuen.2017.10.014","article-title":"Intranasal oxytocin in the treatment of anorexia nervosa: randomized controlled trial during re-feeding","volume":"87","author":"Russell","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.psyneuen.2017.01.017","article-title":"The effects of intranasal oxytocin on smoothie intake, cortisol and attentional bias in anorexia nervosa","volume":"79","author":"Leppanen","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib98","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118327_bib99","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118327_bib100","first-page":"164","article-title":"Leptin influence in craving and relapse of alcoholics and smokers","volume":"5","author":"Aguiar-Nemer","year":"2013","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.723059","article-title":"Leptin gene and leptin receptor gene polymorphisms in alcohol use disorder: findings related to psychopathology","volume":"12","author":"Browning","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib102","first-page":"3861","article-title":"Serum leptin levels in women with anorexia nervosa","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib103","first-page":"948","article-title":"[The changes in serum ghrelin levels and their relationship to IGF-I, its binding proteins and leptin in women patients with anorexia nervosa]","volume":"48","author":"Krsek","year":"2002","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.biopha.2025.118327_bib104","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1210\/jc.2003-032251","article-title":"Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity","volume":"89","author":"Misra","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib105","first-page":"1845","article-title":"Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-3956(02)00100-0","article-title":"The effect of therapeutically induced weight gain on plasma leptin levels in patients with anorexia nervosa","volume":"37","author":"Holtkamp","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib107","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1210\/jc.2003-030569","article-title":"Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa","volume":"88","author":"Holtkamp","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib108","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.mp.4000771","article-title":"Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa","volume":"5","author":"Exner","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib109","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41398-020-00977-1","article-title":"Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects","volume":"10","author":"Milos","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms18020273","article-title":"From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation","volume":"18","author":"Howick","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib111","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-014-3640-0","article-title":"The role of ghrelin in addiction: a review","volume":"231","author":"Panagopoulos","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.irn.2017.08.002","article-title":"The role of the ghrelin system in drug addiction","volume":"136","author":"Zallar","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118327_bib113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2016.11.021","article-title":"Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways","volume":"73","author":"Stievenard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib114","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2013.00148","article-title":"Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward","volume":"7","author":"Schellekens","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib115","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41386-021-01249-2","article-title":"Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral \u03b21 receptors","volume":"47","author":"You","year":"2022","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib116","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41380-022-01438-5","article-title":"Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches","volume":"27","author":"You","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib117","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1389450116666150518095650","article-title":"An integrative review on role and mechanisms of ghrelin in stress, anxiety and depression","volume":"17","author":"Bali","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2025.118327_bib118","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib119","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/diabetes.50.11.2540","article-title":"Ghrelin causes hyperphagia and obesity in rats","volume":"50","author":"Wren","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118327_bib120","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118327_bib121","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.175r001","article-title":"E.E. M\u00fcller, Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients","volume":"175","author":"Rigamonti","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib122","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-1450669","article-title":"M. Tsch\u00f6p, Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa","volume":"145","author":"Otto","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.peptides.2013.02.011","article-title":"The ghrelin activating enzyme ghrelin-O-acyltransferase (GOAT) is present in human plasma and expressed dependent on body mass index","volume":"43","author":"Goebel-Stengel","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2025.118327_bib124","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2006.11.003","article-title":"Family trios analysis of common polymorphisms in the obestatin\/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset","volume":"32","author":"Dardennes","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpsychires.2010.10.001","article-title":"Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa","volume":"45","author":"M\u00fcller","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib126","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.euroneuro.2016.03.010","article-title":"Ghrelin treatment prevents development of activity based anorexia in mice","volume":"26","author":"Legrand","year":"2016","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib127","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-381272-8.00024-6","article-title":"Therapeutic potential of ghrelin in restricting-type anorexia nervosa","volume":"514","author":"Hotta","year":"2012","journal-title":"Methods Enzym."},{"key":"10.1016\/j.biopha.2025.118327_bib128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41593-022-01071-z","article-title":"Genetics and neurobiology of eating disorders","volume":"25","author":"Bulik","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/nu10010071","article-title":"Food addiction and binge eating: lessons learned from animal models","volume":"10","author":"Novelle","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118327_bib130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fpsyg.2014.00372","article-title":"Considerations about rodent models of binge eating episodes","volume":"5","author":"Perello","year":"2014","journal-title":"Front. Psychol."},{"key":"10.1016\/j.biopha.2025.118327_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12751","article-title":"Systems genetic analysis of binge-like eating in a C57BL\/6J x DBA\/2J-F2 cross","author":"Yao","year":"2021","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib132","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1534\/g3.119.400470","article-title":"Cyfip1 haploinsufficiency increases compulsive-like behavior and modulates palatable food intake in mice: dependence on Cyfip2 genetic background, parent-of origin, and sex","volume":"9","author":"Babbs","year":"2019","journal-title":"G3 Bethesda Md"},{"key":"10.1016\/j.biopha.2025.118327_bib133","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2174\/1381612826666200316153317","article-title":"Binge eating and binge drinking: a two-way road? An integrative review","volume":"26","author":"Escriv\u00e1-Mart\u00ednez","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118327_bib134","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0033291709005662","article-title":"Patterns of co-morbidity of eating disorders and substance use in Swedish females","volume":"40","author":"Root","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ilar.53.1.23","article-title":"Rodent models of binge eating: are they models of addiction?","volume":"53","author":"Corwin","year":"2012","journal-title":"ILAR J."},{"key":"10.1016\/j.biopha.2025.118327_bib136","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/eat.20984","article-title":"Striatal dopamine in bulimia nervosa: a PET imaging study","volume":"45","author":"Broft","year":"2012","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib137","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1038\/s41598-020-63389-7","article-title":"Metabotropic glutamate receptor 5 in bulimia nervosa","volume":"10","author":"Mihov","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118327_bib138","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tem.2017.02.006","article-title":"Neural circuit mechanisms underlying emotional regulation of homeostatic feeding","volume":"28","author":"Sweeney","year":"2017","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"10.1016\/j.biopha.2025.118327_bib139","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.biopsych.2016.06.005","article-title":"Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice","volume":"81","author":"Xu","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib140","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1073\/pnas.1909340117","article-title":"Control of food approach and eating by a GABAergic projection from lateral hypothalamus to dorsal pons","volume":"117","author":"Marino","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.appet.2018.11.011","article-title":"Anterior insula activity regulates the associated behaviors of high fat food binge intake and cue reactivity in male rats","volume":"133","author":"Price","year":"2019","journal-title":"Appetite"},{"key":"10.1016\/j.biopha.2025.118327_bib142","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41386-019-0538-x","article-title":"Insula to ventral striatal projections mediate compulsive eating produced by intermittent access to palatable food","volume":"45","author":"Spierling","year":"2020","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib143","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1073\/pnas.1712214114","article-title":"Closing the loop on impulsivity via nucleus accumbens delta-band activity in mice and man","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2025.118327_bib144","article-title":"VIPergic neurons of the infralimbic and prelimbic cortices control palatable food intake through separate cognitive pathways","volume":"5","author":"Newmyer","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118327_bib145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11920-016-0701-6","article-title":"Hormonal Factors and Disturbances in Eating Disorders","volume":"18","author":"Culbert","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.biopha.2025.118327_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.appet.2013.11.018","article-title":"Anticipation of a psychosocial stressor differentially influences ghrelin, cortisol and food intake among emotional and non-emotional eaters","volume":"74","author":"Raspopow","year":"2014","journal-title":"Appetite"},{"key":"10.1016\/j.biopha.2025.118327_bib147","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/eat.22264","article-title":"Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa","volume":"48","author":"Dossat","year":"2015","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib148","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1559827608317358","article-title":"Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder","volume":"2","author":"Geliebter","year":"2008","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.biopha.2025.118327_bib149","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s40501-024-00331-y","article-title":"The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review","volume":"11","author":"Tempia Valenta","year":"2024","journal-title":"Curr. Treat. Options Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118327_bib151","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jnr.490160110","article-title":"Cellular localization of proglucagon\/glucagon-like peptide I messenger RNAs in rat brain","volume":"16","author":"Han","year":"1986","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib152","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib153","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Klausen","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/08039488.2016.1176252","article-title":"Glucagon-like peptide-1 (GLP-1) analogues: a potential new treatment for alcohol use disorder?","volume":"70","author":"Fink-Jensen","year":"2016","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527314666150529144655","article-title":"Glutamate transporter GLT-1 as a THerapeutic Target for Substance Use Disorders","volume":"14","author":"Roberts-Wolfe","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2025.118327_bib156","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","article-title":"Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118327_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102429","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial","volume":"68","author":"L\u00fcthi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biopha.2025.118327_bib158","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/ADM.0000000000001347","article-title":"The efficacy of GLP-1 agonists in treating substance use disorder in patients: a scoping review","volume":"18","author":"Shen","year":"2024","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib159","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2017.12.029","article-title":"Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature","volume":"111","author":"McElroy","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2025.118327_bib160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - A pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obes. Res. Clin. Pr."},{"key":"10.1016\/j.biopha.2025.118327_bib161","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jdiacomp.2011.03.002","article-title":"Psychological and quality of life changes in patients using GLP-1 analogues","volume":"25","author":"Grant","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.biopha.2025.118327_bib162","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.celrep.2015.06.062","article-title":"Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118327_bib163","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn.4540","article-title":"GLP-1 acts on habenular avoidance circuits to control nicotine intake","volume":"20","author":"Tuesta","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib164","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/endo.138.10.5270","article-title":"Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat","volume":"138","author":"Larsen","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib165","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-Like Peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib166","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib167","article-title":"GLP-1 receptor agonists: a novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review","volume":"35","author":"Aoun","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib168","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.biopha.2025.118327_bib169","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuropharm.2014.02.014","article-title":"Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug","volume":"87","author":"Hutson","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0269881109103113","article-title":"Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse","volume":"23","author":"Jasinski","year":"2009","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.biopha.2025.118327_bib171","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2012.07.008","article-title":"Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic\/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity","volume":"63","author":"Rowley","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib172","doi-asserted-by":"crossref","first-page":"pyv009","DOI":"10.1093\/ijnp\/pyv009","article-title":"Preclinical assessment of lisdexamfetamine as an agonist medication candidate for cocaine addiction: effects in rhesus monkeys trained to discriminate cocaine or to self-administer cocaine in a cocaine versus food choice procedure","volume":"18","author":"Banks","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib173","article-title":"LiMA investigator group, lisdexamfetamine in the treatment of methamphetamine dependence: a randomised, placebo-controlled trial","author":"Ezard","year":"2024","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.biopha.2025.118327_bib174","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020723","article-title":"LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence","volume":"8","author":"Ezard","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2025.118327_bib175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/00952990.2021.1885677","article-title":"Open-label pilot study of lisdexamfetamine for cocaine use disorder","volume":"47","author":"Mariani","year":"2021","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.biopha.2025.118327_bib176","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","article-title":"Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"74","author":"Hudson","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib177","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/erv.2418","article-title":"Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder","volume":"24","author":"McElroy","year":"2016","journal-title":"Eur. Eat. Disord. Rev. J. Eat. Disord. Assoc."},{"key":"10.1016\/j.biopha.2025.118327_bib178","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/npp.2015.275","article-title":"Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trials","volume":"41","author":"McElroy","year":"2016","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib179","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"72","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib180","first-page":"22","article-title":"Effects of lisdexamfetamine dimesylate on functional impairment measured on the sheehan disability scale in adults with moderate-to-severe binge eating disorder: results from two randomized, placebo-controlled trials","volume":"15","author":"Sheehan","year":"2018","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib181","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40337-024-01041-9","article-title":"Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder","volume":"12","author":"Griffiths","year":"2024","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib182","first-page":"317","article-title":"Functional connectivity mechanisms underlying symptom reduction following lisdexamfetamine treatment in binge-eating disorder: a clinical trial","volume":"4","author":"Griffiths","year":"2024","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib183","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/JOE-21-0393","article-title":"Naltrexone\/bupropion modifies weight, food intake, and Drd2 gene expression in rats","volume":"253","author":"Roberto da Silva","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib184","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neuropharm.2018.01.035","article-title":"Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats","volume":"135","author":"Levy","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-013-3036-6","article-title":"Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash","volume":"228","author":"Wright","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib186","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obes. Silver Spring Md"},{"key":"10.1016\/j.biopha.2025.118327_bib187","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/acer.13992","article-title":"Bupropion, alone and in combination with naltrexone, blunts binge-like ethanol drinking and intake following chronic intermittent access to ethanol in male C57BL\/6J mice","volume":"43","author":"Navarro","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib188","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/acer.13577","article-title":"Co-administration of low-dose naltrexone and bupropion reduces alcohol drinking in alcohol-preferring (P) rats","volume":"42","author":"Nicholson","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib189","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2019.04.004","article-title":"Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice","volume":"181","author":"Zhou","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4088\/JCP.12m08071","article-title":"Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"74","author":"White","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib191","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0149-2918(02)85141-4","article-title":"Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks","volume":"24","author":"Croft","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2025.118327_bib192","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/oby.2002.142","article-title":"Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms","volume":"10","author":"Jain","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib193","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/oby.2002.86","article-title":"P.M. O\u2019Neil, Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial","volume":"10","author":"Anderson","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib194","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/clpt.1985.197","article-title":"Effects of long-term therapy with naltrexone on body weight in obesity","volume":"38","author":"Atkinson","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118327_bib195","first-page":"347","article-title":"A controlled trial of naltrexone in obese humans","volume":"9","author":"Malcolm","year":"1985","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2025.118327_bib196","first-page":"143","article-title":"Binge eating disorder: response to naltrexone","volume":"19","author":"Marrazzi","year":"1995","journal-title":"Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.biopha.2025.118327_bib197","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinthera.2020.10.010","article-title":"Naltrexone + bupropion combination for the treatment of binge-eating disorder with obesity: a randomized, controlled pilot study","volume":"43","author":"Grilo","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2025.118327_bib198","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/oby.23898","article-title":"Naltrexone\/bupropion for binge-eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Grilo","year":"2023","journal-title":"Obes. Silver Spring Md"},{"key":"10.1016\/j.biopha.2025.118327_bib199","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","article-title":"Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial","volume":"179","author":"Grilo","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cpt.402","article-title":"Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial","volume":"100","author":"Mooney","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118327_bib201","article-title":"Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: a secondary analysis from the CTN ADAPT-2 trial","volume":"151","author":"Schmitz","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"key":"10.1016\/j.biopha.2025.118327_bib202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.addbeh.2009.10.017","article-title":"An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects","volume":"35","author":"Wilcox","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib203","first-page":"56","article-title":"A preliminary, open-label study of naltrexone and bupropion combination therapy for treating binge drinking in human subjects","volume":"55","author":"Walter","year":"2020","journal-title":"Alcohol. Alcohol. Oxf. Oxfs."},{"key":"10.1016\/j.biopha.2025.118327_bib204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbb.2014.11.018","article-title":"Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine","volume":"129","author":"Stoops","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and naltrexone in methamphetamine use disorder","volume":"384","author":"Trivedi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib206","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/add.16529","article-title":"Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial","volume":"119","author":"Li","year":"2024","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.biopha.2025.118327_bib207","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cmet.2018.02.008","article-title":"The homeostatic force of ghrelin","volume":"27","author":"Yanagi","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib208","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118327_bib209","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","article-title":"The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis","volume":"37","author":"Cowley","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118327_bib210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(01)02544-7","article-title":"Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus","volume":"321","author":"Lu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118327_bib211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.regpep.2004.08.038","article-title":"Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus","volume":"126","author":"Mondal","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biopha.2025.118327_bib212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-328X(97)00071-5","article-title":"Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues, Brain Res","volume":"48","author":"Guan","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.biopha.2025.118327_bib213","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.20823","article-title":"Expression of ghrelin receptor mRNA in the rat and the mouse brain","volume":"494","author":"Zigman","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2025.118327_bib214","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/npp.2015.297","article-title":"The stomach-derived hormone ghrelin increases impulsive behavior","volume":"41","author":"Anderberg","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","article-title":"Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens","volume":"12","author":"Jerlhag","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib216","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2008.12.006","article-title":"Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens","volume":"54","author":"Quarta","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118327_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174039","article-title":"A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats","volume":"899","author":"Edvardsson","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib218","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.euroneuro.2015.10.004","article-title":"A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice","volume":"25","author":"Engel","year":"2015","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib219","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.alcohol.2010.10.002","article-title":"The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice","volume":"45","author":"Jerlhag","year":"2011","journal-title":"Alcohol Fayettev. N."},{"key":"10.1016\/j.biopha.2025.118327_bib220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-010-1907-7","article-title":"Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference","volume":"211","author":"Jerlhag","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib221","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.0812809106","article-title":"Requirement of central ghrelin signaling for alcohol reward","volume":"106","author":"Jerlhag","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib222","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2011.01.010","article-title":"Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice","volume":"117","author":"Jerlhag","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2025.118327_bib223","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11064-013-1105-1","article-title":"Ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala","volume":"38","author":"Palotai","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib224","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.physbeh.2010.05.017","article-title":"Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content","volume":"101","author":"Disse","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.physbeh.2010.12.006","article-title":"Systemic ghrelin and reward: effect of cholinergic blockade","volume":"102","author":"Disse","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib226","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1369-1600.2010.00216.x","article-title":"Ghrelin increases intake of rewarding food in rodents","volume":"15","author":"Egecioglu","year":"2010","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib227","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.biopsych.2009.10.030","article-title":"Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner","volume":"67","author":"Perello","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib228","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.yhbeh.2011.08.006","article-title":"Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area","volume":"60","author":"King","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib229","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1369-1600.2010.00294.x","article-title":"Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression","volume":"17","author":"Skibicka","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2011.02.016","article-title":"Ghrelin directly targets the ventral tegmental area to increase food motivation","volume":"180","author":"Skibicka","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118327_bib231","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1152\/ajpregu.00216.2015","article-title":"Central ghrelin increases food foraging\/hoarding that is blocked by GHSR antagonism and attenuates hypothalamic paraventricular nucleus neuronal activation","volume":"310","author":"Thomas","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2025.118327_bib232","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.regpep.2006.12.003","article-title":"Augmented cocaine conditioned place preference in rats pretreated with systemic ghrelin","volume":"140","author":"Davis","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biopha.2025.118327_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134367","article-title":"Role of mesolimbic ghrelin in the acquisition of cocaine reward","volume":"709","author":"Dunn","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118327_bib234","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4236\/jbbs.2013.38060","article-title":"Microinjection of ghrelin into the ventral tegmental area potentiates cocaine-induced conditioned place preference","volume":"3","author":"Schuette","year":"2013","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib235","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/ijms19102925","article-title":"Ghrelin receptor antagonism of methamphetamine-induced conditioned place preference and intravenous self-administration in rats","volume":"19","author":"Havlickova","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118327_bib236","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2017.09.013","article-title":"Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats","volume":"110","author":"Jerabek","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118327_bib237","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12845","article-title":"Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats","volume":"25","author":"Sustkova-Fiserova","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib238","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.peptides.2013.02.008","article-title":"Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference","volume":"43","author":"Bahi","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2025.118327_bib239","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2015.05.026","article-title":"Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence","volume":"97","author":"Gomez","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib240","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/acer.12499","article-title":"The effects of ghrelin antagonists [D-Lys(3)]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL\/6J mice","volume":"38","author":"Gomez","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109643","article-title":"Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice","volume":"238","author":"Richardson","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib242","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.718615","article-title":"Growth Hormone Secretagogue Receptor 1A Antagonist JMV2959 Effectively Prevents Morphine Memory Reconsolidation and Relapse","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib243","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1369-1600.2010.00280.x","article-title":"Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats","volume":"17","author":"Landgren","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1268366","article-title":"Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats","volume":"14","author":"Merritt","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib245","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.psyneuen.2012.10.021","article-title":"Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake","volume":"38","author":"Monteleone","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib246","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/jc.2003-031861","article-title":"Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls","volume":"89","author":"Misra","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib247","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpeds.2003.10.036","article-title":"Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation","volume":"144","author":"Soriano-Guill\u00e9n","year":"2004","journal-title":"J. Pedia"},{"key":"10.1016\/j.biopha.2025.118327_bib248","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4530(02)00066-5","article-title":"Fasting plasma ghrelin levels in subtypes of anorexia nervosa","volume":"28","author":"Tanaka","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib249","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000087923","article-title":"Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones","volume":"81","author":"Troisi","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.physbeh.2010.01.033","article-title":"Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa","volume":"99","author":"Bello","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib251","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1210\/jc.2011-3018","article-title":"Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study","volume":"97","author":"Monteleone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib252","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.metabol.2006.08.003","article-title":"Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects","volume":"55","author":"Calissendorff","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2025.118327_bib253","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/eje.1.01905","article-title":"S. R\u00f6jdmark, Inhibitory effect of alcohol on ghrelin secretion in normal man","volume":"152","author":"Calissendorff","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118327_bib254","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.psyneuen.2013.09.005","article-title":"Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study","volume":"38","author":"Leggio","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/alcalc\/agx022","article-title":"Ghrelin is supressed by intravenous alcohol and is related to stimulant and sedative effects of alcohol","volume":"52","author":"Ralevski","year":"2017","journal-title":"Alcohol. Alcohol. Oxf. Oxfs."},{"key":"10.1016\/j.biopha.2025.118327_bib256","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1369-1600.2006.00026.x","article-title":"Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib257","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1530-0277.2006.00238.x","article-title":"Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients","volume":"30","author":"Addolorato","year":"2006","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib258","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2362.2008.01947.x","article-title":"Alcohol dependence is associated with reduced plasma and fundic ghrelin levels","volume":"38","author":"Badaoui","year":"2008","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118327_bib259","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1097\/01.alc.0000191753.82554.7e","article-title":"Ghrelin levels are increased in alcoholism","volume":"29","author":"Kraus","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib260","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1369-1600.2010.00308.x","article-title":"Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving","volume":"17","author":"Leggio","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib261","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1530-0277.2007.00527.x","article-title":"Gender differences for ghrelin levels in alcohol-dependent patients and differences between alcoholics and healthy controls","volume":"31","author":"Wurst","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118327_bib262","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/mp.2017.226","article-title":"Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals","volume":"23","author":"Farokhnia","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib263","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","article-title":"Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation","volume":"76","author":"Leggio","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib264","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.09.026","article-title":"Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: two streams merge to one river?","volume":"100","author":"Bach","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118327_bib265","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cmet.2008.03.007","article-title":"Ghrelin modulates brain activity in areas that control appetitive behavior","volume":"7","author":"Malik","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118327_bib266","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/adb.12651","article-title":"Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol-addicted subjects: a functional imaging study","volume":"24","author":"Koopmann","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib267","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40263-019-00664-w","article-title":"Potential of cannabinoid receptor ligands as treatment for substance use disorders","volume":"33","author":"Galaj","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2025.118327_bib268","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/jmf.2018.0157","article-title":"\u03b2-caryophyllene, a natural sesquiterpene, attenuates neuropathic pain and depressive-like behavior in experimental diabetic mice","volume":"22","author":"Aguilar-\u00c1vila","year":"2019","journal-title":"J. Med. Food"},{"key":"10.1016\/j.biopha.2025.118327_bib269","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2013.04.013","article-title":"Physicochemical characterization and pharmacokinetics evaluation of \u03b2-caryophyllene\/\u03b2-cyclodextrin inclusion complex","volume":"450","author":"Liu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib270","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/molecules27092860","article-title":"Enhanced oral bioavailability of \u03b2-caryophyllene in healthy subjects using the VESIsorb\u00ae formulation technology, a novel self-emulsifying drug delivery system (SEDDS)","volume":"27","author":"M\u00f6dinger","year":"2022","journal-title":"Mol. Switz."},{"key":"10.1016\/j.biopha.2025.118327_bib271","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1091581816655303","article-title":"Toxicological evaluation of \u03b2-caryophyllene oil: subchronic toxicity in rats","volume":"35","author":"Schmitt","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.biopha.2025.118327_bib272","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/cib.1.1.6568","article-title":"Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?","volume":"1","author":"Gertsch","year":"2008","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib273","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41386-020-00885-4","article-title":"Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPAR\u03b1 and PPAR\u03b3: repurposing a FDA-approved food additive for cocaine use disorder","volume":"46","author":"Galaj","year":"2021","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib274","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2174\/1381612822666160311115226","article-title":"Polypharmacological properties and therapeutic potential of \u03b2-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise","volume":"22","author":"Sharma","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118327_bib275","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","article-title":"The cannabinoid receptor 2 agonist, \u03b2-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice","volume":"124","author":"Al Mansouri","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib276","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"\u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109947","article-title":"\u03b2-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents","volume":"252","author":"Galaj","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib278","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12031-014-0243-5","article-title":"Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-\u03baB activation in microglia","volume":"54","author":"Guo","year":"2014","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.biopha.2025.118327_bib279","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722476","article-title":"\u03b2-caryophyllene, an FDA-approved food additive, inhibits methamphetamine-taking and methamphetamine-seeking behaviors possibly via CB2 and Non-CB2 receptor mechanisms","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib280","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/bph.14969","article-title":"\u03b2-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents","volume":"177","author":"He","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172467","article-title":"\u03b2-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: an in vitro and in vivo study","volume":"858","author":"Al-Taee","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110876","article-title":"Dietary administration of \u03b2-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days","volume":"135","author":"Bastaki","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2025.118327_bib283","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.orcp.2023.10.004","article-title":"Mechanisms of weight-loss effect in obese mice by the endogenous cannabinoid receptor 2 agonist beta-caryophyllene","volume":"17","author":"Jiayao","year":"2023","journal-title":"Obes. Res. Clin. Pr."},{"key":"10.1016\/j.biopha.2025.118327_bib284","first-page":"993","article-title":"\u03b2-caryophyllene, a dietary cannabinoid, protects against metabolic and immune dysregulation in a diet-induced obesity mouse model","volume":"25","author":"Franco-Arroyo","year":"2022","journal-title":"J. Med. Food"},{"key":"10.1016\/j.biopha.2025.118327_bib285","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13249","article-title":"\u03b2-caryophyllene, a cannabinoid receptor 2 agonist, decreases the motivational salience and conditioning place preference for palatable food in female mice","volume":"28","author":"Dos Santos Barbosa","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib286","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib287","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB\u2082 receptors modulate cocaine\u2019s actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib288","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib289","first-page":"269","article-title":"Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid CB2 receptor agonism and CB1 receptor antagonism in rats","volume":"20","author":"Delis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-019-05370-5","article-title":"The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice","volume":"237","author":"Lopes","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib291","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FBP.0000000000000759","article-title":"CB2 agonist mitigates cocaine-induced reinstatement of place preference and modulates the inflammatory response in mice","volume":"35","author":"Abboussi","year":"2024","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2022.106160","article-title":"The effect of \u03b2-caryophyllene on food addiction and its related behaviors: a randomized, double-blind, placebo-controlled trial","volume":"178","author":"Alizadeh","year":"2022","journal-title":"Appetite"},{"key":"10.1016\/j.biopha.2025.118327_bib293","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0376-8716(94)90160-0","article-title":"Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms","volume":"34","author":"Rose","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2025.118327_bib294","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ADM.0000000000000443","article-title":"Topiramate PHarmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review","volume":"13","author":"Manhapra","year":"2019","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.biopha.2025.118327_bib295","first-page":"17","article-title":"Combination phentermine-topiramate extended release for the treatment of binge eating disorder: an open-label, prospective study","volume":"15","author":"Guerdjikova","year":"2018","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2025.118327_bib296","article-title":"Successful treatment of binge eating disorder with combination phentermine\/topiramate extended release","volume":"17","author":"Guerdjikova","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib297","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/eat.23192","article-title":"A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa","volume":"53","author":"Safer","year":"2020","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib298","doi-asserted-by":"crossref","first-page":"493","DOI":"10.9758\/cpn.23.1151","article-title":"An efficient combination therapy with lisdexamfetamine dimesylate and topiramate in improving binge eating scale & metabolic profile in binge eating disorder: a randomized control trial","volume":"22","author":"Mokhtari","year":"2024","journal-title":"Clin. Psychopharmacol. Neurosci. Off. Sci. J. Korean Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib299","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118327_bib300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.biopha.2025.118327_bib301","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40263-024-01111-1","article-title":"Pharmacological treatment of binge eating disorder and frequent comorbid diseases","volume":"38","author":"Himmerich","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2025.118327_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108614","article-title":"Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder","volume":"221","author":"Angarita","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2025.118327_bib303","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/jn\/134.9.2372","article-title":"Fleurbaix laventie ville sante study group, the three-factor eating questionnaire-R18 is able to distinguish among different eating patterns in a general population","volume":"134","author":"de Lauzon","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2025.118327_bib304","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","volume":"27","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118327_bib305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbr.2011.03.003","article-title":"Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference","volume":"221","author":"Landgren","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118327_bib306","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/WNR.0000000000001071","article-title":"Accumbal ghrelin and glucagon-like peptide 1 signaling in alcohol reward in female rats","volume":"29","author":"Abtahi","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2025.118327_bib307","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2018.11.001","article-title":"Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin","volume":"176","author":"You","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2025.118327_bib308","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1369-1600.2011.00396.x","article-title":"A limited role for ghrelin in heroin self-administration and food deprivation-induced reinstatement of heroin seeking in rats","volume":"17","author":"Maric","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.118327_bib309","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00213-014-3466-9","article-title":"Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats","volume":"231","author":"Sustkova-Fiserova","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00213-019-05415-9","article-title":"A role for leptin and ghrelin in the augmentation of heroin seeking induced by chronic food restriction","volume":"237","author":"D\u2019Cunha","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118327_bib311","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/biomedicines11092456","article-title":"Ghrelin amplifies the nicotine-induced release of dopamine in the bed nucleus of stria terminalis (BNST)","volume":"11","author":"Ayman","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118327_bib312","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcp.2018.07.041","article-title":"Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol","volume":"157","author":"Navarrete","year":"2018","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118327_bib313","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2018.11.043","article-title":"Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons","volume":"360","author":"Canseco-Alba","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118327_bib314","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12783","article-title":"Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents","volume":"25","author":"Bi","year":"2020","journal-title":"Addict. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:57:29Z","timestamp":1754654249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":314,"alternative-id":["S0753332225005219"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118327","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118327"}}